Example: Heart Attack

Clinical Trials on Neonatal Onset Multisystem Inflammatory Disease

Total 10 results

NCT00685373

Completed

Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Conditions: Cryopyrin-Associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease
NCT00770601

Terminated

Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease

Conditions: NOMID; CINCA Syndrome
NCT00069329

Terminated

Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease

Conditions: Nervous System Malformations; Arthropathy, Neurogenic; Urticaria; Papilledema
NCT01576367

Completed

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Conditions: Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease
NCT01302860

Completed

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Conditions: Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease
NCT00991146

Completed

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

Conditions: Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease
NCT00438906

Completed

Cancer of the Pancreas Screening Study (CAPS 3)

Conditions: Pancreatic Neoplasm; Peutz-Jeghers Syndrome
NCT01213641

Completed

Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

Conditions: Cryopyrin-associated Periodic Syndromes (CAPS); Familial Cold Autoinflam Syn (FCAS); Muckle-wells Syn (MWS); Neonatal Onset Multisystem Inflam Disease (NOMID)
NCT02853084

Terminated

HL2351 CAPS Phase II Study

Conditions: Cryopyrin-Associated Periodic Syndromes (CAPS)
NCT01105507

Completed

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

Conditions: Cryopyrin Associated Periodic Syndrome